Kaihoujian spray in-vivo plasma pharmaceutical chemical component and confirmation method thereof

The invention relates to in-vivo plasma pharmaceutical chemical components of Kaihoujian spray and a confirmation method thereof. On one hand, the invention relates to a method for confirming the in-vivo active pharmaceutical chemical components of Kaihoujian spray, which comprises the following ope...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZHANG HAI, LONG YINQING, CHEN JINPENG, JIANG LU, WANG JUEBEN, TIAN CHENGWANG
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZHANG HAI
LONG YINQING
CHEN JINPENG
JIANG LU
WANG JUEBEN
TIAN CHENGWANG
description The invention relates to in-vivo plasma pharmaceutical chemical components of Kaihoujian spray and a confirmation method thereof. On one hand, the invention relates to a method for confirming the in-vivo active pharmaceutical chemical components of Kaihoujian spray, which comprises the following operations: providing a high-resolution mass spectrometer and a liquid chromatograph, chromatographic conditions and mass spectrum conditions, administration and blood collection of experimental animals, treatment of a plasma sample, and analysis of the plasma sample. Absorption blood prototype medicine components and metabolism components are determined from various kinds of plasma, and according to the absorption blood prototype medicine common in various kinds of plasma, it is confirmed that the common absorption blood prototype medicine is the plasma active medicine chemical component, and the confirmed plasma active medicine chemical component is trifoliate pterocarpin. The method also comprises the step of confi
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN114942288A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN114942288A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN114942288A3</originalsourceid><addsrcrecordid>eNqNjDEKwkAQRdNYiHqH8QApElPEUoIiCFb2YUhm2Qm7M8vuJuDtDegBrP578PjbAh_IVueJUSCFiG9gKRdeFILD5BGCxehxoDnzgA4GS_4L6oMKSQaUcTUxvHaZVcBTtjpCthRJzb7YGHSJDr_dFcfb9dXdSwraUwrrt1Duu2dVNeemrtv2cvqn-QBw2z6E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Kaihoujian spray in-vivo plasma pharmaceutical chemical component and confirmation method thereof</title><source>esp@cenet</source><creator>ZHANG HAI ; LONG YINQING ; CHEN JINPENG ; JIANG LU ; WANG JUEBEN ; TIAN CHENGWANG</creator><creatorcontrib>ZHANG HAI ; LONG YINQING ; CHEN JINPENG ; JIANG LU ; WANG JUEBEN ; TIAN CHENGWANG</creatorcontrib><description>The invention relates to in-vivo plasma pharmaceutical chemical components of Kaihoujian spray and a confirmation method thereof. On one hand, the invention relates to a method for confirming the in-vivo active pharmaceutical chemical components of Kaihoujian spray, which comprises the following operations: providing a high-resolution mass spectrometer and a liquid chromatograph, chromatographic conditions and mass spectrum conditions, administration and blood collection of experimental animals, treatment of a plasma sample, and analysis of the plasma sample. Absorption blood prototype medicine components and metabolism components are determined from various kinds of plasma, and according to the absorption blood prototype medicine common in various kinds of plasma, it is confirmed that the common absorption blood prototype medicine is the plasma active medicine chemical component, and the confirmed plasma active medicine chemical component is trifoliate pterocarpin. The method also comprises the step of confi</description><language>chi ; eng</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220826&amp;DB=EPODOC&amp;CC=CN&amp;NR=114942288A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220826&amp;DB=EPODOC&amp;CC=CN&amp;NR=114942288A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHANG HAI</creatorcontrib><creatorcontrib>LONG YINQING</creatorcontrib><creatorcontrib>CHEN JINPENG</creatorcontrib><creatorcontrib>JIANG LU</creatorcontrib><creatorcontrib>WANG JUEBEN</creatorcontrib><creatorcontrib>TIAN CHENGWANG</creatorcontrib><title>Kaihoujian spray in-vivo plasma pharmaceutical chemical component and confirmation method thereof</title><description>The invention relates to in-vivo plasma pharmaceutical chemical components of Kaihoujian spray and a confirmation method thereof. On one hand, the invention relates to a method for confirming the in-vivo active pharmaceutical chemical components of Kaihoujian spray, which comprises the following operations: providing a high-resolution mass spectrometer and a liquid chromatograph, chromatographic conditions and mass spectrum conditions, administration and blood collection of experimental animals, treatment of a plasma sample, and analysis of the plasma sample. Absorption blood prototype medicine components and metabolism components are determined from various kinds of plasma, and according to the absorption blood prototype medicine common in various kinds of plasma, it is confirmed that the common absorption blood prototype medicine is the plasma active medicine chemical component, and the confirmed plasma active medicine chemical component is trifoliate pterocarpin. The method also comprises the step of confi</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDEKwkAQRdNYiHqH8QApElPEUoIiCFb2YUhm2Qm7M8vuJuDtDegBrP578PjbAh_IVueJUSCFiG9gKRdeFILD5BGCxehxoDnzgA4GS_4L6oMKSQaUcTUxvHaZVcBTtjpCthRJzb7YGHSJDr_dFcfb9dXdSwraUwrrt1Duu2dVNeemrtv2cvqn-QBw2z6E</recordid><startdate>20220826</startdate><enddate>20220826</enddate><creator>ZHANG HAI</creator><creator>LONG YINQING</creator><creator>CHEN JINPENG</creator><creator>JIANG LU</creator><creator>WANG JUEBEN</creator><creator>TIAN CHENGWANG</creator><scope>EVB</scope></search><sort><creationdate>20220826</creationdate><title>Kaihoujian spray in-vivo plasma pharmaceutical chemical component and confirmation method thereof</title><author>ZHANG HAI ; LONG YINQING ; CHEN JINPENG ; JIANG LU ; WANG JUEBEN ; TIAN CHENGWANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN114942288A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHANG HAI</creatorcontrib><creatorcontrib>LONG YINQING</creatorcontrib><creatorcontrib>CHEN JINPENG</creatorcontrib><creatorcontrib>JIANG LU</creatorcontrib><creatorcontrib>WANG JUEBEN</creatorcontrib><creatorcontrib>TIAN CHENGWANG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHANG HAI</au><au>LONG YINQING</au><au>CHEN JINPENG</au><au>JIANG LU</au><au>WANG JUEBEN</au><au>TIAN CHENGWANG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Kaihoujian spray in-vivo plasma pharmaceutical chemical component and confirmation method thereof</title><date>2022-08-26</date><risdate>2022</risdate><abstract>The invention relates to in-vivo plasma pharmaceutical chemical components of Kaihoujian spray and a confirmation method thereof. On one hand, the invention relates to a method for confirming the in-vivo active pharmaceutical chemical components of Kaihoujian spray, which comprises the following operations: providing a high-resolution mass spectrometer and a liquid chromatograph, chromatographic conditions and mass spectrum conditions, administration and blood collection of experimental animals, treatment of a plasma sample, and analysis of the plasma sample. Absorption blood prototype medicine components and metabolism components are determined from various kinds of plasma, and according to the absorption blood prototype medicine common in various kinds of plasma, it is confirmed that the common absorption blood prototype medicine is the plasma active medicine chemical component, and the confirmed plasma active medicine chemical component is trifoliate pterocarpin. The method also comprises the step of confi</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN114942288A
source esp@cenet
subjects INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
title Kaihoujian spray in-vivo plasma pharmaceutical chemical component and confirmation method thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T14%3A08%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHANG%20HAI&rft.date=2022-08-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN114942288A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true